In a previous communication, we showed that 3-adrenergic stimulation of cardiac muscle was associated with an increase in the rate of cycling of crossbridges as measured by perturbation analysis in the frequency domain. In this analysis, the frequency at which dynamic stiffness is a minimum (f.in) is taken as a measure of the rate of crossbridge cycling. In this paper, we test the hypothesis that the /-adrenergic receptor-induced increase in crossbridge cycling rate is mediated by elevation of the intracellular level of cyclic AMP. The approach taken is to compare the eflects on fmin in rat papillary muscles during Ba2+-activated contractures of 1) an agonist of cyclic AMP that can easily penetrate the cell, namely, dibutyryl cyclic AMP, 2) agents that block cyclic AMP phosphodiesterase, namely, the xanthine derivatives isobutylmethylxanthine and caffeine, and 3) an inotropic agent that does not affect the intracellular level of cyclic AMP, namely, ouabain. Our results showed that dibutyryl cyclic AMP at a dose of 5 mM has the same actions as ,-adrenergic stimulation: it potentiated the isometric twitch force, reduced the time to peak tension and time to half relaxation, and shifted fmin by a factor of 1.8+0.1 (n=5). Isobutylmethylxanthine at up to 1.1 mM also acted in the same manner, increasing fmin by a factor of 1.8+0.2 (n=6), but ouabain, at a dose (0.03 mM) sufficient to potentiate twitch force by 40+2% (n =4), was without effect on the time course of the twitch nor was fmin changed (n =4).
T he mechanical manifestations of ,B-adrenergic stimulation of the myocardium in the time domain are well known: increase in the maximal speed of shortening, increase in the rate of rise of isometric tension, increase in peak twitch tension, and decrease in time to peak (TTP) and time to half relaxation (TT½/2R). These changes have been generally regarded as satisfactorily explained by an increase in the number of activated crossbridges as a result of enhanced numbers of activated troponin C by calcium ions.1 '2 Using frequency-domain analysis of dynamic stiffness, we3 have recently shown that f8-adrenergic stimulation of rat papillary muscle in Ba21-activated contracture is associated with a shift, in the direction of higher frequency, of the dynamic stiffness and phase-versus-frequency plots. Such shifts can be quantified by noting the change in the frequency at which dynamic stiffness exhibits a minimum (fmin).
,3-Adrenergic stimulation is associated with an increase in fmin in an isomyosin-dependent manner: for heart tissue rich in V1 isomyosin (V1 hearts), the increase is 50%, whereas for heart tissue rich in V3 isomyosin (V3 hearts), the increase is 25%.3 A similar observation has been reported by Berman et a14 with rabbit papillary muscle. Such a shift in fmin is interpreted as a change in crossbridge dynamics; the rationale for such an interpretation is supported by the work of others5-8 and by our own contributions9-11 in which we demonstrated a correlation between the mechanical and the myothermic and biochemical properties of muscle rich in V, and V3 isomyosins. We concluded8 that /3-adrenergic stimulation causes an enhancement in the rate of crossbridge cycling and that this effect of 13-adrenergic stimulation is independent of the effects of ,B-adrenergic stimulation on the number of active crossbridges during contraction.
Many different mechanical parameters have been used as a measure of myocardial contractility, such as the maximal speed of shortening and the rates of rise of tension or pressure. These parameters ultimately depend at the molecular level on two basic parameters, namely, the number of active crossbridges during contraction and the rate at which they cycle. Thus, 13-adrenergic receptor-mediated cardiac inotropy is associated with an enhancement of both parameters. The product of the extensive factor (number of active crossbridges) and the intensive factor (cycling rate) defines the hydrolysis rate of ATP, the mechanical power and rate of tensionrelated heat liberation, and hence the contractility of the myocardium.
,B-Adrenergic agents are currently thought to act on target cells in two ways. The first is the wellestablished pathway whereby ,B-adrenergic agents activate a stimulatory G protein (GQ), which in turn elevates an intracellular second messenger, cAMP, by the activation of adenylate cyclase. Recently, it has been shown that f3-adrenergic receptor-stimulated G, can also directly regulate calcium channels in mammalian cardiac cells independent of cAMP.12 It would seem more plausible that ,B-adrenergic action on crossbridge cycling is mediated via the cAMP system, since Gs, a low abundance membrane protein in the sarcolemma, is qualitatively and quantitatively inept to act directly on crossbridges. If ,B-adrenergic receptor-mediated enhancement of crossbridge cycling is indeed brought about via cAMP, the following predictions can be made on the effects of positive inotropic agents on crossbridge kinetics: 1) agonists of cAMP as well as agents that elevate intracellular cAMP should also enhance crossbridge cycling rate, and 2) inotropic agents that do not elevate intracellular cAMP should have no effect on crossbridge cycling rate.
In the present study, we attempted to verify these predictions on the effects of various inotropic agents on crossbridge cycling rate, using Ba2+-activated rat papillary muscles and pseudo-random binary noise (PRBN)-modulated length perturbations to carry out dynamic stiffness analysis. The effects on dynamic stiffness and consequently on crossbridge cycling rate of four positive inotropic agents, dibutyryl cAMP (DcAMP), isobutylmethylxanthine (IBMX), caffeine, and ouabain, were analyzed. In addition, the actions of these inotropic agents on isometric twitch characteristics of parallel preparations of papillary muscle were also analyzed using the same concentrations of drugs as those for frequency-domain analyses. These results enabled correlations to be made between results obtained using frequency-domain analyses with those using time-domain methods.
It will be shown that dibutyryl cAMP and the xanthine derivatives that inhibit cAMP phosphodiesterase enhance the crossbridge cycling rate, whereas ouabain, which does not affect the cAMP system, has no such action. These experiments imply that ,3-adrenergic stimulation enhances crossbridge cycling rate in cardiac muscle by elevating the intracellular level of cAMP.
Materials and Methods

Experimental Apparatus and Data Analysis
Perturbation of muscle length was achieved by means of an electromagnetic vibrator (Ling Altec, Royston, England),13 and muscle force was measured by means of a piezoresistive strain gauge (model 801, Akers, Horten, Norway). The muscle bath was a rectangular prism cut from a solid aluminum block. Temperature control was achieved by means of a Peltier device (model 801-2001-01, Cambion, Comatsu Electronics, Tokyo), and all experiments were carried out at 25°C. A detailed description is given in a previous paper. 3 Electrical stimulation of intact muscle was achieved via platinum wire electrodes located 5 mm on either side of the muscle. The rectangular stimulating pulses had a strength of 40 V and width of 2 msec. At 25°C, pulse frequency was 12 pulses/min.
The signal used to perturb the length of the muscle was software-generated and was introduced to the muscle via digital-to-analog conversion and the length driver. The length signal and the resulting force response of the muscle were passed back to the control computer (model lOOOE, Hewlett-Packard Co., Palo Alto, Calif.) via analog-to-digital conversion and stored on hard disk. When all the required dynamic length-tension records had been collected, the data files were processed by means of fast Fourier transforms to yield dynamic stiffness and phase values. The data were smoothed, using a three-point convolution procedure, and displayed on a digital plotter (model 7225A, Hewlett-Packard). The signal used to perturb the length of the muscle was PRBN. A detailed description of this signal and the associated data analysis are given in a previous article. 14 The shape of the dynamic stiffness and phase plots obtained by means of small-amplitude PRBN length perturbation agree with those obtained when using small-amplitude sinusoidal length perturbation.14 The plots displayed a characteristic minimum in stiffness and accompanying minimum/maximum feature in phase response ( Figure 6 ). They are in agreement with plots obtained by other investigators who used sinusoids for perturbing muscle length.1'5"6 fmin corresponds to the point of inflection in the rising part of the phase curve.
Solutions
The 
Muscle Preparation
The experiments were carried out on papillary muscles taken from the right ventricle of SpragueDawley rats. V1 hearts were obtained from 3-5-week-old rats; V3 hearts were obtained from mature rats that had been treated with propylthiouracil. 17 The rats were killed by decapitation, and each heart was immediately removed via a sternotomy and placed in the standard solution kept at 25°C. As described previously,3 a long, thin papillary muscle was selected from the right ventricle and secured between force gauge and length driver.
Experimental Protocol
After mounting, the muscle was stretched by 30% of its resting length to the operating length (L), and the Ca2+-free solution was replaced with standard solution. Lo is about 95% of the length at which the muscle produces maximum twitch force. The muscle was electrically stimulated every 5 seconds, and the isometric twitch was displayed on a digitizing oscilloscope (model 5223, Tektronix, Beaverton, Ore.) and on a chart recorder (model 7402A, Hewlett-Packard).
To ensure that the observed inotropic effects are those of the unadulterated muscle, the experiments on isometric twitches and on fmin were done on separate papillary preparations.
Effect of Inotropic Agents on Isometric Twitch
When the isometric twitch response had stabilized, it was recorded by means of a Polaroid oscilloscope camera (model C59A, Tektronix) and was taken as the control response. The inotropic agent was then added to the standard solution in the muscle bath, and the time course of its effect on the twitch profile was recorded by means of the Polaroid camera.
Effect of Inotropic Agents on f,in
After the twitch had stabilized, the muscle was washed in several changes of Ca2+-free solution until the twitch force had become negligibly small.9,18 The Ca2+-free solution was then replaced by the Ba2+-contracture solution leading to the development of contracture tension. When the contracture tension had stabilized, the control computer recorded the dynamic length and tension signals. This recording formed the control response. Inotropic agents were added to the muscle bath as described above, followed by mechanical perturbation analyses to monitor the time course of their effect on f,i, Effect of IBMX on Twitch and fmin in the Presence of Propranolol
Procedures were followed as above; however, the muscle was allowed to equilibrate for 10 minutes in the presence of propranolol (3 ,ug/ml) before the addition of IBMX.
Results
Effect of IBMX, DcAMP, and Ouabain on Isometric
Twitch Parameters Figure 1 shows the effect of inotropic agents, IBMX, DcAMP, and ouabain, on the time course of the twitch force profile of the V,-type papillary muscles. In all cases, the agent potentiated twitch force. DcAMP and IBMX, but not ouabain, had the additional effect of accelerating the time course of the twitch. IBMX and DcAMP share these properties with adrenaline.3 The potentiating effect of adrenaline on twitch force and speed is blocked by propranolol.3 As shown in Figure 2 and Table 1 , unlike adrenaline, the potentiating effect of IBMX on twitch force and speed was not blocked by propranolol (by paired t test, p>0.1) but was delayed. Without propranolol, it took 4.1+0.3 minutes (mean+SEM; n =7) for the effect of IBMX on the twitch profile to reach steady state, whereas in the presence of propranolol the time taken was 6.3+0.9 minutes (mean+SEM; n=6).
To quantify the effect of the inotropic agents on the isometric twitch profile, we measured the following parameters: isometric force, T1P, and TT/2R. The ratios (experimental/control) for these parameters are plotted against time in Figures Figure 5 . In contrast to the potentiating effect of the three inotropic agents on isometric twitch, no well-defined effect was evident on their contractural tension.
Analysis of the PRBN length changes and the resulting force changes of recording 5 in Figure 5 gave rise to the characteristic dynamic stiffness and phase data shown in Figure 6i , which displays a minimum in dynamic stiffness at a characteristic frequency accompanied by the minimum/maximum feature in the phase response.916 fmf corresponds to the point of inflection in the rising part of the phase curve. The effect of adding IBMX (0.6 mM) to a V,-type muscle is shown to shift the dynamic stiffness and phase curves to higher frequencies, indicating that IBMX initiated an increase in crossbridge dynamics. 6, 8, 9 The effect of DcAMP on dynamic stiffness and phase is similar to that of IBMX (Figure 6ii ). Figure 6iii . There is no shift in fmin between the control response and the ouabain response up to 30 minutes after the addition of the drug. The insensitivity of the twitch parameters, TTP and TT/2R, to this drug (Figure 4 ), whereas the increase in fmini brought about by IBMX and DcAMP, indicating a speeding up in crossbridge dynamics, is accompanied by a shortening of the duration of the isometric twitch force ( Table 1) . The lack of effect of ouabain on fmfin was confirmed in four V1-type muscles and one V3-type muscle. This relation is further elaborated on in Figure 8 , in which these twitch parameters obtained at various times after application of IBMX and DcAMP are plotted against fmin values obtained at corresponding times in parallel preparations after the application of the drugs at the same concentrations. The plots were obtained from the means of the measured values of the twitch parameters and fmin at set times after the addition of the inotropic agent. The inverse relation between TTP and TT½2R against fmin is consistent with the hypothesis that, in the case of IBMX, DcAMP, and adrenaline, the increase in twitch speed is partially brought about by an increase in the rate of crossbridge cycling. The similarity of the relations suggests a common mechanism of action between the inotropic agents IBMX, DcAMP, and adrenaline. The corresponding correlation of twitch force with fminis shown in Figure 9 . The corresponding increase in twitch force for a particular fmin is greater for IBMX than for DcAMP or adrenaline.
Effect of Caffeine on Isometric Twitch Parameters and fmin
Caffeine, also a methylxanthine and a phosphodiesterase inhibitor but well known to have other pharmacological effects, displays an effect different from that of IBMX. As shown in Table 1 Figure 5 for IBMX effect, gave rise to dynamic stiffness and phase data at 350 -25 equally spaced frequencies in the range 0. The mechanism of action of cardiac glycosides does not involve the cAMP system.31,32 Cardiac glycosides block sarcolemmal Na+,K'-ATPase, thereby increasing the intracellular Na+ concentration. This decreases the amount of Ca21 transported out of the myocyte via the Na'-Ca2' exchange mechanism, thereby increasing the intracellular Ca21 pool. As a result, more Ca2' enters the cell, and a Ca2+ transient of greater magnitude can be recorded intracellularly.33,34 Our results on the action of ouabain on the isometric twitch contractions also confirmed previous reports that cardiac glycosides have little effect on the time course of the isometric twitch. 35 In particular, ouabain does not accelerate the rate of isometric twitch relaxation, which is so prominent a feature in the action of catecholamines336 and of IBMX and DcAMP reported here. Cardiac glycosides mobilize Ca2+ to produce an increase in the number of crossbridges activated but leave crossbridge kinetics unaffected. The absence of an effect on fmmI is consistent with this view.
Effects of the Inotropic Agents on the Mechanics of Cardiac Muscle
Before our recent study,3 the mechanical effects of intropic agents have only been studied in the time domain.37 The force-velocity relation is generally regarded as a fundamental property of skeletal muscles. Quick-release experiments showed that DcAMP,20 the methylxanthines,2628 the cardiac glycosides,35,38 and indeed most inotropic interventions37 shifted the force-velocity curve of cardiac muscle upward and to the right, increasing maximal velocity of shortening at zero external load as well as increasing the maximal force of isometric contraction. For cardiac muscle, an increase in maximal velocity of shortening may result from an increase in either the level of activation39,40 or in the crossbridge cycling rate.3,9,41 Therefore, cardiac force-velocity data fail to distinguish between the two possible fundamental mechanisms for enhancing contractility: the number of active crossbridges and the rate at which they cycle (see the introductory section).
Although the mechanical effects on cardiac muscle of catecholamine, cAMP analogues, phosphodiesterase inhibitors, and cardiac glycosides are indistinguishable by force-velocity analysis, our data showed that the profiles of the isometric twitch, which are much easier to obtain than force-velocity data, paradoxically do reveal a difference in actions of various inotropic agents. Adrenaline, DcAMP, and IBMX showed a reduced T1P and TT½/2R, whereas ouabain did not affect these parameters.
These time-domain results are strongly correlated with results of frequency-domain analysis.
The importance of frequency-domain analysis in cardiac muscle mechanics lies in its ability to resolve changes in fmm, a parameter indicative of crossbridge The possibility that the time course of the cardiac isometric twitch may reflect the time course of the crossbridge cycle gives a new insight to the studies of Sonnenblick35 in the 1960s on the effects of noradrenaline and strophanthidin on the active-state curves of cat papillary muscles. Sonnenblick found that strophanthidin shifted the active-state curve vertically, whereas noradrenaline shifted the activestate curve upward and to the left, reducing the time taken to reach peak active state and accelerating the rate of its decay. These results correlate with our findings that ouabain did not increase fmin but adrenaline did.3 This correlation suggests that the time course of the active state as measured by Sonnenblick reflects crossbridge kinetics.
It should be noted, however, that adrenaline also phosphorylates phospholamban,2 resulting in reaccumulation of Ca21 ions by the sarcoplasmic reticulum.
This action, which is not shared by ouabain, may also have an influence on the active state.
Our data on adrenaline, DcAMP, and IBMX also showed that twitch force is directly correlated with fmin. This simply reflects the fact that cAMP has the dual effect of increasing the number of active crossbridges by mobilizing Ca2' as well as enhancing crossbridge cycling rate. It is of interest, however, that the slope of the regression line relating force and fmmi for IBMX is considerably higher than that for DcAMP and adrenaline. The reason for this difference is obscure. A possible explanation is that there exist different pools of intracellular cAMP and that different inotropic agents affect these pools differently. 
Difference in Response Between
